We have long been bedeviled by questions about some of the short- and the long-term side effects and complications of androgen deprivation therapy (ADT) in the treatment of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, Alzheimer's, androgen, dementia, deprivation, failure, heart, side effect | 2 Comments »
A new study has concluded that added risk for Alzheimer’s disease and dementia among Medicare patients with prostate cancer who were treated with androgen deprivation therapy (ADT) was minimal in men treated between 2001 and 2014. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, Alzheimer's, androgen, dementia, deprivation | 1 Comment »
Back in December last year, a group of researchers suggested that androgen deprivation therapy (ADT) might be associated with increased risk for Alzheimer’s disease (see “Is ADT giving you Alheimer’s disease?“) … READ MORE …
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, Alzheimer's, androgen, dementia, deprivation, risk | 11 Comments »
Late last year we reported on a study in the Journal of Clinical Oncology that suggested the possibility of a link between androgen deprivation therapy (ADT) and the onset of Alzheimer’s disease. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: ADT, Alzheimer's, androgen, deprivation, risk, therapy | 2 Comments »
A newly published article in the Journal of Clinical Oncology has demonstrated an association between treatment with androgen deprivation therapy (ADT) and risk for diagnosis with Alzheimer’s disease among prostate cancer patients at an average of 3 years of follow-up. However, … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: ADT, Alzheimer's, androgen, deprivation, function, mental | 7 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 